Long term efficacy of intraperitoneal Paclitaxel plus S-1/paclitaxel in gastric cancer patients with peritoneal dissemination
Latest Information Update: 20 Feb 2018
Price :
$35 *
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Paclitaxel (Primary)
- Indications Gastric cancer
- Focus Adverse reactions; Therapeutic Use
- 20 Feb 2018 New trial record
- 20 Jan 2018 Results presented at the 2018 Gastrointestinal Cancers Symposium